4560 Horton Street
Grifols Diagnostic division provides innovative solutions to support safe and compatible transfusions, monitor therapies, and detect infectious and autoimmune diseases. We also explore development of molecular testing and other novel technologies with the potential to further improve treatment outcomes and laboratory efficiency.
Our broad product portfolio is designed to deliver fast and accurate information for healthcare providers working to select the safest and most effective treatments for patients. As a leader in transfusion medicine, Grifols is proud that blood banks and transfusion centers around the world trust our automated laboratory systems, broad test menu, and expert service and support to address their full range of blood screening and pre-transfusion testing needs.